Adults aged more than 70 who received more prescriptions for nirmatrelvir-ritonavir did not show decreased rates of ...

The all-or-nothing strategy has landed the ‘pride of the pharmaceutical industry' in a situation that deteriorated rapidly.

Tixagevimab-cilgavimab reduced risk for severe COVID-19 progression in patients with hematologic malignancies on anti-CD20 therapy during the early Omicron era.

A live-updating map of novel coronavirus cases by zip code, courtesy of ESRI/JHU. Click on an area or use the search tool to enter a zip code. Use the + and - buttons to zoom in and out on the map.